[Fundamental and clinical studies on the measurement of beta 2-microglobulin as a tumor marker using the Dainabot beta 2-micro-radioimmunoassay kit]. 1986

K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D005260 Female Females
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
June 1987, Kaku igaku. The Japanese journal of nuclear medicine,
K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
January 1985, Kaku igaku. The Japanese journal of nuclear medicine,
K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
April 1985, Kaku igaku. The Japanese journal of nuclear medicine,
K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
February 1985, Kaku igaku. The Japanese journal of nuclear medicine,
K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
August 1982, Horumon to rinsho. Clinical endocrinology,
K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
December 1982, Kaku igaku. The Japanese journal of nuclear medicine,
K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
July 1980, Horumon to rinsho. Clinical endocrinology,
K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
February 1990, Nihon rinsho. Japanese journal of clinical medicine,
K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
August 1984, Kaku igaku. The Japanese journal of nuclear medicine,
K Yoshida, and Y Ichiya, and Z Ayabe, and Y Kuwabara, and M Wada, and A Ueyama, and K Matsuura
December 1976, Kaku igaku. The Japanese journal of nuclear medicine,
Copied contents to your clipboard!